Have a personal or library account? Click to login
Causal Relationship between Gut Microbiota and Pulmonary Embolism: An Analysis Using Mendelian Randomization Cover

Causal Relationship between Gut Microbiota and Pulmonary Embolism: An Analysis Using Mendelian Randomization

Open Access
|Jun 2025

References

  1. Archambaud C, Derré-Bobillot A, Lapaque N, Rigottier-Gois L, Serror P. Intestinal translocation of enterococci requires a threshold level of enterococcal overgrowth in the lumen. Sci Rep. 2019 Jun 20;9(1):8926. https://doi.org/10.1038/s41598-019-45441-3
  2. Ballard RB, Marques MB; Education Committee of the Academy of Clinical Laboratory Physicians and Scientists. Pathology consultation on the laboratory evaluation of thrombophilia: When, how, and why. Am J Clin Pathol. 2012 Apr;137(4):553–560. https://doi.org/10.1309/ajcp5sqt3zkyqfbm
  3. Barcik W, Boutin RCT, Sokolowska M, Finlay BB. The role of lung and gut microbiota in the pathology of asthma. Immunity. 2020 Feb;52(2):241–255. https://doi.org/10.1016/j.immuni.2020.01.007
  4. Birney E. Mendelian randomization. Cold Spring Harb Perspect Med. 2022 May;12(4):a041302. https://doi.org/10.1101/cshper-spect.a041302
  5. Budden KF, Gellatly SL, Wood DL, Cooper MA, Morrison M, Hugenholtz P, Hansbro PM. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2017 Jan;15(1):55–63. https://doi.org/10.1038/nrmicro.2016.142
  6. Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O’Connell J, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018 Oct;562(7726):203–209. https://doi.org/10.1038/s41586-018-0579-z
  7. Dang AT, Marsland BJ. Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. 2019 Jul;12(4):843–850. https://doi.org/10.1038/s41385-019-0160-6
  8. Freuer D, Linseisen J, Meisinger C. Asthma and the risk of gastrointestinal disorders: A Mendelian randomization study. BMC Med. 2022 Mar;20(1):82. https://doi.org/10.1186/s12916-022-02283-7
  9. Fujita Y, Iki M, Tamaki J, Kouda K, Yura A, Kadowaki E, Sato Y, Moon JS, Tomioka K, Okamoto N, et al. Association between vitamin K intake from fermented soybeans, natto, and bone mineral density in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study. Osteoporos Int. 2012 Feb;23(2):705–714.https://doi.org/10.1007/s00198-011-1594-1
  10. Gonzalez-Hernandez J, Daoud Y, Styers J, Journeycake JM, Channabasappa N, Piper HG. Central venous thrombosis in children with intestinal failure on long-term parenteral nutrition. J Pediatr Surg. 2016 May;51(5):790–793. https://doi.org/10.1016/j.jpedsurg.2016.02.024
  11. Hasan RA, Koh AY, Zia A. The gut microbiome and thromboembolism. Thromb Res. 2020 May;189:77–87. https://doi.org/10.1016/j.thromres.2020.03.003
  12. Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017 Nov;13(11):e1007081. https://doi.org/10.1371/journal.pgen.1007081
  13. Jäckel S, Kiouptsi K, Lillich M, Hendrikx T, Khandagale A, Kollar B, Hörmann N, Reiss C, Subramaniam S, Wilms E, et al. Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2. Blood. 2017 Jul;130(4):542–553. https://doi.org/10.1182/blood-2016-11-754416
  14. Kaplan D, Casper TC, Elliott CG, Men S, Pendleton RC, Kraiss LW, Weyrich AS, Grissom CK, Zimmerman GA, Rondina MT. VTE incidence and risk factors in patients with severe sepsis and septic shock. Chest. 2015 Nov;148(5):1224–1230. https://doi.org/10.1378/chest.15-0287
  15. Kappelman MD, Horvath-Puho E, Sandler RS, Rubin DT, Ullman TA, Pedersen L, Baron JA, Sørensen HT. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: A population-based nationwide study. Gut. 2011 Jul;60(7):937–943. https://doi.org/10.1136/gut.2010.228585
  16. Konikoff T, Gophna U. Oscillospira: a Central, enigmatic component of the human gut microbiota. Trends Microbiol. 2016 Jul;24(7):523–524. https://doi.org/10.1016/j.tim.2016.02.015
  17. Koropatkin NM, Cameron EA, Martens EC. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol. 2012 Apr;10(5):323–335. https://doi.org/10.1038/nrmicro2746
  18. Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A, Le Roy CI, Raygoza Garay JA, Finn-icum CT, Liu X, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021 Feb;53(2):156–165. https://doi.org/10.1038/s41588-020-00763-1
  19. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: Human gut microbes associated with obesity. Nature. 2006 Dec;444(7122):1022–1023. https://doi.org/10.1038/4441022a
  20. Lima S, Longman RS. A diamond in the rough: IgA-seq signatures stratify new onset IBD. Cell Host Microbe. 2021 Jan;29(1):10–12. https://doi.org/10.1016/j.chom.2020.12.014
  21. Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol. 2023 Apr;20(4):248–262. https://doi.org/10.1038/s41569-022-00787-6
  22. Meng MJ, Chung CS, Chang CW, Pan YB, Kuo CJ, Chiu CT, Le PH. the incidence and predictive factors of thromboembolism during hospitalizations for inflammatory bowel disease flare-ups: A retrospective cohort study in Taiwan. J Eval Clin Pract. 2024 Nov. https://doi.org/10.1111/jep.14231
  23. R Core Team. A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2023 [cited 2024 Nov 14]. Available from https://www.r-project.org
  24. Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, et al.; ISTH Steering Committee for World Thrombosis Day. Thrombosis: A major contributor to global disease burden. Arte-rioscler Thromb Vasc Biol. 2014 Nov;34(11):2363–2371. https://doi.org/10.1161/atvbaha.114.304488
  25. Saghazadeh A, Rezaei N. Inflammation as a cause of venous thromboembolism. Crit Rev Oncol Hematol. 2016 Mar;99:272–285. https://doi.org/10.1016/j.critrevonc.2016.01.007
  26. Tamana SK, Tun HM, Konya T, Chari RS, Field CJ, Guttman DS, Becker AB, Moraes TJ, Turvey SE, Subbarao P, et al. Bacteroi-des-dominant gut microbiome of late infancy is associated with enhanced neurodevelopment. Gut Microbes. 2021 Jan–Dec;13(1):1–17. https://doi.org/10.1080/19490976.2021.1930875
  27. Vaishnavi C. Translocation of gut flora and its role in sepsis. Indian J Med Microbiol. 2013 Oct–Dec;31(4):334–342. https://doi.org/10.4103/0255-0857.118870
  28. Walther B, Karl JP, Booth SL, Boyaval P. Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements. Adv Nutr. 2013 Jul;4(4):463–473. https://doi.org/10.3945/an.113.003855
  29. Wang HB, Wang PY, Wang X, Wan YL, Liu YC. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci. 2012 Dec;57(12):3126–3135. https://doi.org/10.1007/s10620-012-2259-4
  30. Wang Y, Hong G, Yang Y, Li Z, Li Z, Zhou H, et al. (2023) Genetic Evidence Supports a Causal Role of the Gut Microbiome in Venous Thromboembolism. Front Immunol. 14:1301689. https://doi.org/10.3389/fimmu.2023.1301689
  31. Wei Y, Lu X, Liu C. Gut microbiota and chronic obstructive pulmonary disease: A Mendelian randomization study. Front Microbiol. 2023 Jun;14:1196751. https://doi.org/10.3389/fmicb.2023.1196751
  32. Xi L, Wang H, Du J, Liu A, Wang J, Ni Y, Zhang S, Xie W, Liu M, Wang C. Causal effect of gut microbiota on venous thromboembolism: A two-sample Mendelian randomization study. Thromb J. 2024 Nov;22(1):106. https://doi.org/10.1186/s12959-024-00676-7
  33. Xu N, Bai X, Cao X, Yue W, Jiang W, Yu Z. Changes in intestinal microbiota and correlation with TLRs in ulcerative colitis in the coastal area of northern China. Microb Pathog. 2021 Jan;150:104707. https://doi.org/10.1016/j.micpath.2020.104707
  34. Yang J, Li Y, Wen Z, Liu W, Meng L, Huang H. Oscillospira – A candidate for the next-generation probiotics. Gut Microbes. 2021 Jan–Dec;13(1):1987783. https://doi.org/10.1080/19490976.2021.1987783
  35. Zafar H, Saier MH Jr. Gut Bacteroides species in health and disease. Gut Microbes. 2021 Jan–Dec;13(1):1–20. https://doi.org/10.1080/19490976.2020.1848158
  36. Zhang Z, Chen H, Huang J, Zhang S, Li Z, Kong C, Mao Y, Han B. early administration of vancomycin inhibits pulmonary embolism by remodeling gut microbiota. J Pers Med. 2023 Mar;13(3):537. https://doi.org/10.3390/jpm13030537
  37. Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, Li L, Fu X, Wu Y, Mehrabian M, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016 Mar;165(1):111–124. https://doi.org/10.1016/j.cell.2016.02.011
DOI: https://doi.org/10.33073/pjm-2025-013 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 153 - 164
Submitted on: Dec 16, 2024
|
Accepted on: Apr 9, 2025
|
Published on: Jun 18, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 LILAN CEN, LING QIN, WANLING CHEN, LIHUA WEI, CAIXIA TANG, XIANG TENG, ZHE TIAN, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.